Buy Davoceticept Biosimilar - Anti-CTLA-4, PD-L1, CD28 fusion protein - Research Grade

Skip to main content

Contact Book a call

Contact Book a call

Size	100ug, 1MG
Brand	ProteoGenix
Product type	Recombinant Proteins
Expression system	XtenCHO
Applications	Elisa, WB

ELISA WB Recombinant Proteins PD1 - PDL1 - PDL2 Therapeutic Proteins - Biosimilars Cancer

Product name	Davoceticept Biosimilar - Anti-CTLA-4, PD-L1, CD28 fusion protein - Research Grade
Expression system	XtenCHO
Purity	>90% by SDS-PAGE.
Buffer	0.01M PBS, pH 7.4.
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	4°C for short term; -20°C for long term
Brand	ProteoGenix
Applications	ELISA,WB
Aliases /Synonyms	anti-CTLA-4, PD-L1, CD28
Reference	PX-TA2009
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	Fusion - [CD80 (B7-1, CD28LG1) fragment (1-107)]2 - IGHG1 Fc (Fragment constant)

Datasheet Download

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Davoceticept Biosimilar – Anti-CTLA-4, PD-L1, CD28 fusion protein – Research Grade”

Price and Availability

Size

Clear

GET A QUOTE NOW

OK

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us

Related products

Tumor-associated calcium signal transducer 2(TACSTD2)

Antigen

Tumor-associated calcium signal transducer 2(TACSTD2)

PX-P4569 210€

View product

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.

Cart (0 Items)

Your cart is currently empty.